Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

PDL BioPharma (PDLI)

Add to Watchlists
Create an Alert
8.61 +0.06  +0.70% NASDAQ Apr 23, 10:41AM BATS Real time Currency in USD
View Full Chart
PDLI Price Chart
View All Events

PDLI Events

Date Type Description
Dec 03 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Dec 12 2014
Sep 03 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Sep 12 2014
Jun 03 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Jun 12 2014
Mar 12 Misc PDL Biopharma Announces 2014 Regular Quarterly Dividends
Mar 03 Misc PDL BioPharma, Inc. Q4 2013 Earning Conference Call
Mar 03 Earnings PDL BioPharma, Inc. Q4 2013 Earning Result. Estimate: 0.41.
Mar 03 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Mar 12 2014
Dec 31 Misc PDL Biopharma Provides Fourth Quarter 2013 Revenue Guidance of $109 Million
Dec 12 Misc PDL BioPharma Completes Regular Quarterly Dividend Payment
Dec 03 Dividends Amount: 0.15, Declared Date: Jan 23 2013, Pay Date: Dec 12 2013
View All Performance Charts

PDLI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PDL BioPharma is up 20.71% over the last year vs S&P 500 Total Return up 22.75%, Actelion up 69.21%, and Roche Holding up 22.84%.

Get Quote for

PDF Report for PDLI

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download PDLI Pro Report PDF
Advertisement

Portfolio Strategies Featuring PDLI

Did PDL BioPharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PDLI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Nevada
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

PDL BioPharma, Inc., is engaged in the discovery of a new generation of targeted treatments for cancer & immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets & maximizing value of its patent.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PDLI 8.61 +0.06 +0.70% 1.381B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.